Rezolute, Inc. Welcomes Pharmaceutical Industry Leader Philippe Fauchet to its Board of Directors
REDWOOD CITY, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Rezolute, Inc. (“Rezolute” or “the Company”) (OTCQB:RZLT), announced today that the Company has appointed veteran global healthcare executive Philippe Fauchet, O.B.E. to its board of directors.
Philippe has spent more than 35 years in the pharmaceutical industry, including most recently as the chairman of GlaxoSmithKline Japan where he joined as president & representative director in 2010. Previously, he served as senior vice president, corporate business development, head of Sanofi-Aventis Group and as a member of the Management Committee. Philippe is currently a director and senior advisor to several biotech companies, as well as a venture partner in an investment firm.
Nevan Elam, Rezolute’s chief executive officer, said, “We are thrilled to add Philippe to our board and believe that he will make tremendous contributions as we continue to evolve. Philippe’s insights on market dynamics and strategic relationships will be a critical asset especially as our lead program, RZ358, progresses through late-stage clinical trials.”
About Rezolute, Inc.
Exhibit Hall Grand Opening Reception - Hall D
Time: 5:00-7:00 pm
Real-time Insights: A Case Study for the Next Generation of Smart Construction Ecosystem